Menu
Back to User profile » Dr Susan Bolge
Papers published by Dr Susan Bolge:
Patient engagement in type 2 diabetes mellitus research: what patients want
Simacek KF, Nelson T, Miller-Baldi M, Bolge SC
Patient Preference and Adherence 2018, 12:595-606
Published Date: 20 April 2018
Health care provider experience with canagliflozin in real-world clinical practice: favorability, treatment patterns, and patient outcomes
Bolge SC, Flores NM, Huang S, Cai J
International Journal of General Medicine 2017, 10:177-187
Published Date: 23 June 2017
Patient experience with intravenous biologic therapies for ankylosing spondylitis, Crohn’s disease, psoriatic arthritis, psoriasis, rheumatoid arthritis, and ulcerative colitis
Bolge SC, Eldridge HM, Lofland JH, Ravin C, Hart PJ, Ingham MP
Patient Preference and Adherence 2017, 11:661-669
Published Date: 28 March 2017
The association of weight loss with patient experience and outcomes in a population of patients with type 2 diabetes mellitus prescribed canagliflozin
Gerlanc NM, Cai J, Tkacz J, Bolge SC, Brady BL
Diabetes, Metabolic Syndrome and Obesity 2017, 10:89-99
Published Date: 20 March 2017
Openness to and preference for attributes of biologic therapy prior to initiation among patients with rheumatoid arthritis: patient and rheumatologist perspectives and implications for decision making
Bolge SC, Goren A, Brown D, Ginsberg S, Allen I
Patient Preference and Adherence 2016, 10:1079-1090
Published Date: 16 June 2016
Reasons for discontinuation of subcutaneous biologic therapy in the treatment of rheumatoid arthritis: a patient perspective
Bolge SC, Goren A, Tandon N
Patient Preference and Adherence 2015, 9:121-131
Published Date: 20 January 2015